Literature DB >> 18772050

Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).

Robert D Oades1.   

Abstract

Poor control of attention-related and motor processes, often associated with behavioural or cognitive impulsivity, are typical features of children and adults with attention-deficit hyperactivity disorder (ADHD). Until recently clinicians have observed little need to improve on or add to the catecholaminergic model for explaining the features of ADHD. Recent genetic and neuroimaging studies however provide evidence for separate contributions of altered dopamine (DA) and serotonin (5-HT) function in this disorder. Genetic studies imply that for both DA and 5-HT systems variants may frequently occur in ADHD for neurotransmitter uptake, synthesis and breakdown functions. The separate distributions in the brain of mesolimbic DA transporter and mesocortical DA D4 binding sites, both strongly implicated in ADHD, draws attention to potentially differential contributions from the 5-HT system. However, the evidence here points less towards an anatomical differentiation, as towards one in terms of inhibitory/facilitatory pre/post-synaptic location of receptors in the 5-HT(1) and 5-HT(2) families. While the monoamine metabolite levels excreted in ADHD are often correlated, this may well flow from a starting point where 5-HT activity is anomalously higher or lower than the generally lower than normal levels for DA. It appears that perhaps both situations may arise reflecting different diagnostic subgroups of ADHD, and where impulsive characteristics of the subjects reflect externalizing behaviour or cognitive impulsivity. For these features there is clear evidence that DA and 5-HT neuronal systems can and do interact anomalously in ADHD at the level of the soma, the terminals and at a distance. Interactions mediated by macroglia are also likely. However, it remains difficult to ascribe specific mechanisms to their effects (in potentially different subgroups of patients) from this relatively new field of study that has as yet produced rather heterogeneous results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772050     DOI: 10.1016/S0079-6123(08)00926-6

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  47 in total

1.  Contributions of the orbitofrontal cortex to impulsive choice: interactions with basal levels of impulsivity, dopamine signalling, and reward-related cues.

Authors:  Fiona D Zeeb; Stan B Floresco; Catharine A Winstanley
Journal:  Psychopharmacology (Berl)       Date:  2010-04-29       Impact factor: 4.530

Review 2.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

3.  Prioritization of candidate genes for attention deficit hyperactivity disorder by computational analysis of multiple data sources.

Authors:  Suhua Chang; Weina Zhang; Lei Gao; Jing Wang
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

Review 4.  Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD).

Authors:  June Bryan de la Peña; Irene Joy Dela Peña; Raly James Custodio; Chrislean Jun Botanas; Hee Jin Kim; Jae Hoon Cheong
Journal:  Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.590

Review 5.  Association of Serotonin Receptors with Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis.

Authors:  Yu-Wei Hou; Ping Xiong; Xue Gu; Xin Huang; Min Wang; Jing Wu
Journal:  Curr Med Sci       Date:  2018-06-22

6.  Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication.

Authors:  Robert D Oades; Maria R Dauvermann; Benno G Schimmelmann; Markus J Schwarz; Aye-Mu Myint
Journal:  Behav Brain Funct       Date:  2010-05-28       Impact factor: 3.759

Review 7.  Molecular genetics of attention-deficit/hyperactivity disorder: an overview.

Authors:  Tobias Banaschewski; Katja Becker; Susann Scherag; Barbara Franke; David Coghill
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-02-10       Impact factor: 4.785

Review 8.  Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder.

Authors:  Nanda N J Rommelse; Barbara Franke; Hilde M Geurts; Catharina A Hartman; Jan K Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-02-11       Impact factor: 4.785

9.  Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention.

Authors:  Robert D Oades; Aye-Mu Myint; Maria R Dauvermann; Benno G Schimmelmann; Markus J Schwarz
Journal:  Behav Brain Funct       Date:  2010-06-09       Impact factor: 3.759

10.  Evidence for epistasis between the 5-HTTLPR and the dopamine D4 receptor polymorphisms in externalizing behavior among 15-year-olds.

Authors:  Sarah Hohmann; Katja Becker; Johannes Fellinger; Tobias Banaschewski; Martin H Schmidt; Günter Esser; Manfred Laucht
Journal:  J Neural Transm (Vienna)       Date:  2009-12       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.